These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2958657)

  • 1. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
    Yudelman I
    Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
    Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
    Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism.
    van Hulsteijn H; Bertina R; Briët E
    Thromb Res; 1982 Jul; 27(2):225-9. PubMed ID: 6182625
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism.
    van Hulsteijn H; Briët E; Koch C; Hermans J; Bertina R
    Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis activation markers in acute renal failure.
    Stefanidis I; Frank D; Maurin N
    Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
    Wojciechowski J; Olausson M; Korsan-Bengtsen K
    Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
    Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
    Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
    Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
    Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
    Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
    Rosove MH; Hocking WG; Harwig SS; Perloff JK
    Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers of hemostasis activation in nephrotic syndrome.
    Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
    Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
    Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
    Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
    Maeda M; Kachi H; Kitajima Y
    J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in spinal cord injury.
    Fujii Y; Mammen EF; Farag A; Muz J; Salciccioli GG; Weingarden ST
    Thromb Res; 1992 Dec; 68(4-5):357-68. PubMed ID: 1290164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.